More PRNewswire
View Older Stories View Newer Stories-
Larry Robbins and Longwood Hockey Acquire Palm Beach Ice Works and Palm Beach Breakers from Philanthropist Lori Alf
-
7 Alliance College-Ready Public Schools Recognized as 2024 California Distinguished Schools
-
Office Beacon Rebrands as Flowz - Staffing Simplified
-
Flash News: OKX Introduces Exclusive 'Babylon Pioneer Pass Event' in Collaboration with Babylon, Offering Free Pioneer Pass NFT Minting for the First 100,000 Users Who Stake on Babylon Testnet
-
NEXT Properties announces extension of the Expiration Date, the granting of withdrawal rights and payment of a Cash Payment Consideration in connection with its debt exchange offers for Fibra Uno's se
-
Midwest Energy Emissions Corp. Wins $57 Million Delaware Patent Infringement Verdict with Caldwell Cassady & Curry as Lead Trial Counsel
-
FINN Partners and Humble Ventures 'Future of Health' Summit Returns to Austin on Saturday, March 9 at The Cathedral
-
Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
-
Texas Panhandle Wildfires: U-Haul Offering 30 Days Free Storage
-
Dave Mier to Continue as Interim CFO
-
/C O R R E C T I O N -- Lexus/
-
Highland Opportunities and Income Fund Announces the Regular Monthly Distribution
-
Pacific Cataract and Laser Institute, Inc., P.C. NOTICE OF DATA EVENT
-
MAA to Present at the 2024 Citi Global Property CEO Conference
-
SMH Sports & Entertainment Announces Exciting New Partnership Between Woodforest Bank and the Houston SaberCats Rugby Team
-
SMX Appoints Ofira Bar as Chief Financial Officer
-
VISIT DENVER'S 20TH ANNUAL RESTAURANT WEEK KICKS OFF TODAY
-
PDAC 2024 Closes the Market
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
-
Fast Guard Service Ensures the Safety of Youth Sporting Events Nationwide
-
The Dallas Opera's 2024/2025 Season Features Four Classic Titles with Two New-to-Dallas Premieres
-
Natural Grocers® Announces Fifth Annual 'Celebrate Colorado' Event
-
PHILADELPHIA TRANSPORTATION WORKERS JOIN TEAMSTERS LOCAL 623
-
Couchbase Announces New Employee Inducement Grants
-
Prologis to Participate in Industry Conferences
-
MSC INDUSTRIAL SUPPLY CO. TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES
-
Isabella Bank Corporation Announces First Quarter 2024 Dividend
-
FDA Roundup: March 1, 2024
-
JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS
-
JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS
-
Spirit AeroSystems Confirms Discussions with Boeing
-
Obesity Action Coalition (OAC) Mobilizes Advocates on Capitol Hill to Mark the Start of Obesity Care Week 2024
-
STEWART INFORMATION SERVICES CORPORATION ANNOUNCES CASH DIVIDEND
-
MAA Announces Regular Quarterly Preferred Dividend
-
Boeing Statement on Discussions with Spirit AeroSystems
-
PNM Resources Board Declares Quarterly Common Stock Dividend
-
Verkada Releases 2024 Impact Report, Commits to Reaching Net Zero Emissions by 2045
-
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
-
Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
-
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rexford Industrial to Present at the Citi 2024 Global Property CEO Conference
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
American Healthcare REIT to Present at Citi 2024 Global Property CEO Conference
-
Marissa Mayer Elected to AT&T Board of Directors
-
Thornburg Income Builder Opportunities Trust Announces Distribution
-
1/ST ANNOUNCES $25 MILLION ON THE LINE WITH INTRODUCTION OF NEW RACING SERIES LINKING PREAKNESS 149, CALIFORNIA CROWN AND 2025 PEGASUS WORLD CUP
-
Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care
-
RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutat
